FTSE 100 movers: JD Sports surges on update; pharma stocks in the red

16:26, 9th April 2025

London's FTSE 100 was down 2.6% at 7,707.53 in afternoon trade on Wednesday.
Pharma giants GSK and AstraZeneca both fell sharply after Trump said on Tuesday that the US would soon announce a "major" tariff on pharmaceutical imports.

JD Sports shot to the top of the index as it said that full-year profits were set to be in line with previous guidance and announced the launch of a £100m share buyback.

The company said trading to the end of March has been as it expected. For FY25, the group expects organic revenue growth of 5.8% and profit before tax and adjusting items in line with January guidance of £915m to £935m.

For FY26, JD currently expects profit before tax and adjusting items to be in line with consensus expectations of between £878m and £982m, but this excludes any potential impact from changes to tariffs.

Precious metals miner Fresnillo shone as gold prices advanced amid a flight to safety.

 

FTSE 100 - Risers

JD Sports Fashion (JD.) 68.74p 8.83%
Fresnillo (FRES) 869.50p 0.87%
Airtel Africa (AAF) 148.00p 0.20%
RELX FINANCE BV 3.375% GTD NTS 20/03/33 (BW73) 99.72p 0.00%
Next (NXT) 11,000.00p -0.14%
BAE Systems (BA.) 1,563.00p -0.22%
Auto Trader Group (AUTO) 727.00p -0.41%
Diageo (DGE) 2,030.00p -0.64%
BT Group (BT.A) 150.20p -0.73%
3i Group (III) 3,518.00p -0.76%

FTSE 100 - Fallers

AstraZeneca (AZN) 9,641.00p -7.07%
Intermediate Capital Group (ICG) 1,550.00p -6.12%
GSK (GSK) 1,258.50p -6.12%
BP (BP.) 333.50p -5.86%
Schroders (SDR) 285.60p -5.74%
Melrose Industries (MRO) 383.20p -5.73%
Land Securities Group (LAND) 494.60p -5.25%
Smurfit Westrock (DI) (SWR) 2,946.00p -4.94%
Scottish Mortgage Inv Trust (SMT) 815.80p -4.81%
Persimmon (PSN) 1,090.50p -4.80%

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Watchlist